Cuba – Notícias, Pesquisa e Análise – The Conversation – página 1
Browse Cuba news, research and analysis from The Conversation
Stay updated with breaking news from Robert Baloh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Browse Cuba news, research and analysis from The Conversation
Novartis’s acquisition of DTx Pharma brings a lead program for a rare disease with no FDA-approved therapies. But the deal could also help the pharma giant bring new RNA therapies to new places in the body, a top Novartis executive explained.
The acquisition of DTx Pharma by drug giant Novartis includes the potential for an additional $500 million payout depending on reaching certain pre-determined milestones
/PRNewswire/ -- DTx Pharma, invested and incubated by Viva BioInnovator (VBI), is a preclinical stage biotechnology company addressing the delivery challenges...
DTx Pharma is a preclinical stage biotechnology company that focuses on developing siRNA therapies for neuroscience indications, leveraging its proprietary fatty acid...